Cessna Aircraft unit is planning to cut 2,000 more workers in its second round of layoffs in recent weeks.
More: continued here
Archive for January 13th, 2009
Textron Falls on Cessna Job Cuts (TheStreet.com)
Tuesday, January 13th, 2009Elan Mulling Possible Sale, Merger (TheStreet.com)
Tuesday, January 13th, 2009Dublin’s Elan has hired Citigroup Global Markets to review alternatives, including a minority investment, an alliance, or a merger or sale of the company.
More: continued here
TSC Ratings’ Updates: NuStar (TheStreet.com)
Tuesday, January 13th, 2009HCC Insurance and NuStar are upgraded; Braksem, BOK Financial and Ecolab are downgraded.
More: continued here
CSX Sees Profit Below Estimates (TheStreet.com)
Tuesday, January 13th, 2009Fourth-quarter earnings per share should rise roughly 6% from the same period a year earlier.
More: continued here
Sony to Post Huge Operating Loss: Reports (TheStreet.com)
Tuesday, January 13th, 2009The electronics company will post a $1.1 billion operating loss this fiscal year through March, its first since 1995, media reports said, as sales of liquid crystal display screens and other products fall.
More: continued here
‘Mad Money Lightning Round’: Turn Off RadioShack (TheStreet.com)
Tuesday, January 13th, 2009Cramer said he doesn’t want to have anything to do with consumer electronics.
More: continued here
Nortel Continues to March Upward (TheStreet.com)
Tuesday, January 13th, 2009Investors favor Nortel amid ‘Second Life’ talk, Ethernet rumors.
More: continued here
Asian Stocks Mixed; Nikkei Falls 4.1% (TheStreet.com)
Tuesday, January 13th, 2009A report that electronics company Sony would post a massive fiscal-year operating loss sent stocks in Japan lower by more than 4%.
More: continued here
Bristol-Myers to Buy Rights to Hep C Drug (TheStreet.com)
Tuesday, January 13th, 2009Bristol-Myers has agreed to pay $85 million upfront to ZymoGenetics for rights to PEG-Interferon lambda and will pay another $20 million license fee to ZymoGenetics in 2009, the companies announced Monday.
More: continued here